Zobrazeno 1 - 10
of 13
pro vyhledávání: '"van Hoogstraten LMC"'
Autor:
Pijpers OM; Department of Urology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., van Hoogstraten LMC; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Remmers S; Department of Urology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Beijert IJ; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Oddens JR; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Alfred Witjes J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Kiemeney LA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands., Boormans JL; Department of Urology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: j.boormans@erasmusmc.nl.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Nuijens ST; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands. Electronic address: sieb.nuijens@radboudumc.nl., van Osch FHM; Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands; Department of Epidemiology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands., van Hoogstraten LMC; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands., Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands., Hermans TJN; Department of Urology, VieCuri Medical Center, Venlo, the Netherlands; Department of Urology, Maastricht University Medical Center, Maastricht, The Netherlands.
Publikováno v:
Urologic oncology [Urol Oncol] 2024 Apr; Vol. 42 (4), pp. 117.e11-117.e16. Date of Electronic Publication: 2024 Jan 17.
Autor:
Brück K; Department of Radiotherapy, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Netherlands Comprehensive Cancer Organization, Nijmegen, The Netherlands. Electronic address: k.brueck@amsterdamumc.nl., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., van Hoogstraten LMC; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organization, Nijmegen, The Netherlands., van der Heijden MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Donders AR; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Franckena M; Department of Radiotherapy, Erasmus MC, Rotterdam, The Netherlands., Uyl de Groot CA; Institute for Medical Technology Assessment, Rotterdam, The Netherlands; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands., Leliveld AM; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands., Aben KKH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organization, Nijmegen, The Netherlands., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Jan 01; Vol. 118 (1), pp. 41-49. Date of Electronic Publication: 2023 Jul 28.
Autor:
van Hoogstraten LMC; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands. l.vanhoogstraten@iknl.nl.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. l.vanhoogstraten@iknl.nl., Man CCO; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands., Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands., Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands., Mulder SF; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Ripping TM; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publikováno v:
World journal of urology [World J Urol] 2023 Jul; Vol. 41 (7), pp. 1837-1845. Date of Electronic Publication: 2023 May 31.
Autor:
de Haar-Holleman A; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., van Hoogstraten LMC; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: l.vanhoogstraten@iknl.nl., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, the Netherlands., Tascilar M; Department of Oncology, Isala Hospital, Zwolle, the Netherlands., Brück K; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, the Netherlands., Meijer RP; Department of Urology, Radboud university medical center, Nijmegen, the Netherlands., Alfred Witjes J; Department of Urology, Radboud university medical center, Nijmegen, the Netherlands., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, the Netherlands., Aben KKH; Department of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Jun; Vol. 183, pp. 109584. Date of Electronic Publication: 2023 Mar 01.
Autor:
van Hoogstraten LMC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands.; Department for Health Evidence, Radboud university medical center (Radboudumc), Nijmegen, Netherlands., Vrieling A; Department for Health Evidence, Radboud university medical center (Radboudumc), Nijmegen, Netherlands., van der Heijden AG; Department of Urology, Radboudumc, Nijmegen, Netherlands., Kogevinas M; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Richters A; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands.; Department for Health Evidence, Radboud university medical center (Radboudumc), Nijmegen, Netherlands., Kiemeney LA; Department for Health Evidence, Radboud university medical center (Radboudumc), Nijmegen, Netherlands. Bart.Kiemeney@radboudumc.nl.; Department of Urology, Radboudumc, Nijmegen, Netherlands. Bart.Kiemeney@radboudumc.nl.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2023 May; Vol. 20 (5), pp. 287-304. Date of Electronic Publication: 2023 Mar 13.
Autor:
Nuijens ST; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., van Hoogstraten LMC; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands., Kiemeney LA; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands., Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2023 Mar 31; Vol. 51, pp. 47-54. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).
Autor:
Ripping TM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501, DB, Utrecht, the Netherlands., Rammant E; King's College London, Faculty of Life Sciences & Medicine, Translational Oncology & Urology Research (TOUR), London, UK.; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Aaronson NK; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Hemelrijck M; King's College London, Faculty of Life Sciences & Medicine, Translational Oncology & Urology Research (TOUR), London, UK., van Hoogstraten LMC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501, DB, Utrecht, the Netherlands., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501, DB, Utrecht, the Netherlands. k.aben@iknl.nl.; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands. k.aben@iknl.nl.
Publikováno v:
Health and quality of life outcomes [Health Qual Life Outcomes] 2022 Dec 29; Vol. 20 (1), pp. 171. Date of Electronic Publication: 2022 Dec 29.
Autor:
van Hoogstraten LMC; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands., Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands., Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, the Netherlands., Ripping TM; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
Publikováno v:
BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 764-775. Date of Electronic Publication: 2022 Feb 08.
Autor:
van Hoogstraten LMC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands., van Leenders GJLH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Vanneste BGL; Department of Radiation Oncology, MAASTRO-clinic, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Incrocci L; Department of Radiation Oncology, Erasmus MCCancer Institute, Rotterdam, the Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, Netherlands., Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
Publikováno v:
Bladder cancer (Amsterdam, Netherlands) [Bladder Cancer] 2022 Jun 03; Vol. 8 (2), pp. 139-154. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).